Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancers

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

npj Precision Oncology

Topics

Biology

Molecular Biology

Cancer Research

Colorectal Cancer

Cancer

Show all topics

DOI

10.1038/s41698-024-00615-9

License

CC-BY

Other Formats

PDF